Why carry out this study?

Although cancer patients are at a high risk of developing venous thromboembolism (VTE), it is not known whether the risk will continue after cancer remission; thus, the kind of treatment or preventive measure that should be applied to patients after cancer remission remains unclear

This study was conducted based on the assumption that the risk of VTE will decrease over time after cancer remission

What was learned from the study?

During the 30 days after cancer remission, the incidence of VTE was high, with a risk similar to that in patients with cancer, but this slowly decreased, and after 2 years, the risk of developing VTE decreased to the same level as that in patients without cancer

Defining the period in which there is a high risk of developing VTE after cancer remission will lead to prevention and early diagnosis of VTE